These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20957396)

  • 1. Lipid glycation and protein glycation in diabetes and atherosclerosis.
    Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
    Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
    Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
    Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycation of plasma lipoprotein lipid membrane and screening for lipid glycation inhibitor.
    Nakagawa K; Ibusuki D; Yamashita S; Miyazawa T
    Ann N Y Acad Sci; 2008 Apr; 1126():288-90. PubMed ID: 18448833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of AGEs formation by natural products.
    Nagai R; Shirakawa J; Ohno R; Moroishi N; Nagai M
    Amino Acids; 2014 Feb; 46(2):261-6. PubMed ID: 23504149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
    Karachalias N; Babaei-Jadidi R; Kupich C; Ahmed N; Thornalley PJ
    Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor.
    Higuchi O; Nakagawa K; Tsuzuki T; Suzuki T; Oikawa S; Miyazawa T
    J Lipid Res; 2006 May; 47(5):964-74. PubMed ID: 16470027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients.
    Suzuki K; Nakagawa K; Miyazawa T
    Clin Chem Lab Med; 2014 Jan; 52(1):47-52. PubMed ID: 23454716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
    Khalifah RG; Baynes JW; Hudson BG
    Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated proteins in diabetes.
    Furth AJ
    Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.
    Lapolla A; Fedele D; Seraglia R; Traldi P
    Mass Spectrom Rev; 2006; 25(5):775-97. PubMed ID: 16625652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.
    Thornalley PJ; Langborg A; Minhas HS
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):109-16. PubMed ID: 10548540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation endproducts and cigarette smoking.
    Nicholl ID; Bucala R
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.